JP2018501358A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501358A5 JP2018501358A5 JP2017532699A JP2017532699A JP2018501358A5 JP 2018501358 A5 JP2018501358 A5 JP 2018501358A5 JP 2017532699 A JP2017532699 A JP 2017532699A JP 2017532699 A JP2017532699 A JP 2017532699A JP 2018501358 A5 JP2018501358 A5 JP 2018501358A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- copolymer
- bis
- alkyl
- repeat units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001577 copolymer Polymers 0.000 claims 36
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 6
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 150000003973 alkyl amines Chemical class 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000001408 amides Chemical class 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- -1 aryl sulfonic acids Chemical class 0.000 claims 6
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- 125000004970 halomethyl group Chemical group 0.000 claims 6
- 125000004404 heteroalkyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 239000003431 cross linking reagent Substances 0.000 claims 5
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 claims 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 4
- 150000004820 halides Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 3
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims 2
- LFKLPJRVSHJZPL-UHFFFAOYSA-N 1,2:7,8-diepoxyoctane Chemical compound C1OC1CCCCC1CO1 LFKLPJRVSHJZPL-UHFFFAOYSA-N 0.000 claims 2
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 claims 2
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 claims 2
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 claims 2
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 claims 2
- YQMXOIAIYXXXEE-UHFFFAOYSA-N 1-benzylpyrrolidin-3-ol Chemical compound C1C(O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-UHFFFAOYSA-N 0.000 claims 2
- JTINZFQXZLCHNS-UHFFFAOYSA-N 2,2-bis(oxiran-2-ylmethoxymethyl)butan-1-ol Chemical compound C1OC1COCC(CO)(CC)COCC1CO1 JTINZFQXZLCHNS-UHFFFAOYSA-N 0.000 claims 2
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 claims 2
- DCFMPVOLRQDQHW-UHFFFAOYSA-N 2,6-bis(oxiran-2-ylmethyl)pyrrolo[3,4-f]isoindole-1,3,5,7-tetrone Chemical compound O=C1C2=CC(C(N(CC3OC3)C3=O)=O)=C3C=C2C(=O)N1CC1CO1 DCFMPVOLRQDQHW-UHFFFAOYSA-N 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 2
- DVPBWLLOGOINDW-UHFFFAOYSA-N 2-(5-bromo-1h-indol-3-yl)acetamide Chemical compound C1=C(Br)C=C2C(CC(=O)N)=CNC2=C1 DVPBWLLOGOINDW-UHFFFAOYSA-N 0.000 claims 2
- AMFIUYBZYJZWAU-UHFFFAOYSA-N 2-(benzhydryloxymethyl)oxirane Chemical compound C1OC1COC(C=1C=CC=CC=1)C1=CC=CC=C1 AMFIUYBZYJZWAU-UHFFFAOYSA-N 0.000 claims 2
- AGIBHMPYXXPGAX-UHFFFAOYSA-N 2-(iodomethyl)oxirane Chemical compound ICC1CO1 AGIBHMPYXXPGAX-UHFFFAOYSA-N 0.000 claims 2
- OOCUYWYPDMKZOQ-UHFFFAOYSA-N 2-(oxiran-2-yl)ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCC1OC1 OOCUYWYPDMKZOQ-UHFFFAOYSA-N 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 2
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 claims 2
- HAZWONBCJXKAMF-UHFFFAOYSA-N 2-[1-[1,3-bis[2-(oxiran-2-ylmethoxy)propoxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC(OCC(C)OCC1OC1)COCC(C)OCC1CO1 HAZWONBCJXKAMF-UHFFFAOYSA-N 0.000 claims 2
- KVSHGEMJMXSNTB-UHFFFAOYSA-N 2-[2,2,3,3,4,4,5,5-octafluoro-6-(oxiran-2-yl)hexyl]oxirane Chemical compound C1OC1CC(F)(F)C(F)(F)C(F)(F)C(F)(F)CC1CO1 KVSHGEMJMXSNTB-UHFFFAOYSA-N 0.000 claims 2
- HTJFSXYVAKSPNF-UHFFFAOYSA-N 2-[2-(oxiran-2-yl)ethyl]oxirane Chemical compound C1OC1CCC1CO1 HTJFSXYVAKSPNF-UHFFFAOYSA-N 0.000 claims 2
- SEFYJVFBMNOLBK-UHFFFAOYSA-N 2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxymethyl]oxirane Chemical compound C1OC1COCCOCCOCC1CO1 SEFYJVFBMNOLBK-UHFFFAOYSA-N 0.000 claims 2
- CFHWRTNORXTUDE-UHFFFAOYSA-N 2-[6-(oxiran-2-yl)hexyl]oxirane Chemical compound C1OC1CCCCCCC1CO1 CFHWRTNORXTUDE-UHFFFAOYSA-N 0.000 claims 2
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 claims 2
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 claims 2
- FSYPIGPPWAJCJG-UHFFFAOYSA-N 2-[[4-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1OCC1CO1 FSYPIGPPWAJCJG-UHFFFAOYSA-N 0.000 claims 2
- IGZBSJAMZHNHKE-UHFFFAOYSA-N 2-[[4-[bis[4-(oxiran-2-ylmethoxy)phenyl]methyl]phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1C(C=1C=CC(OCC2OC2)=CC=1)C(C=C1)=CC=C1OCC1CO1 IGZBSJAMZHNHKE-UHFFFAOYSA-N 0.000 claims 2
- TUGYYYCKWFHYSY-UHFFFAOYSA-N 2-bromo-3-ethyloxirane Chemical compound CCC1OC1Br TUGYYYCKWFHYSY-UHFFFAOYSA-N 0.000 claims 2
- FDAYLTPAFBGXAB-UHFFFAOYSA-N 2-chloro-n,n-bis(2-chloroethyl)ethanamine Chemical compound ClCCN(CCCl)CCCl FDAYLTPAFBGXAB-UHFFFAOYSA-N 0.000 claims 2
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 claims 2
- QRJZGVVKGFIGLI-UHFFFAOYSA-N 2-phenylguanidine Chemical group NC(=N)NC1=CC=CC=C1 QRJZGVVKGFIGLI-UHFFFAOYSA-N 0.000 claims 2
- MECNWXGGNCJFQJ-UHFFFAOYSA-N 3-piperidin-1-ylpropane-1,2-diol Chemical compound OCC(O)CN1CCCCC1 MECNWXGGNCJFQJ-UHFFFAOYSA-N 0.000 claims 2
- AHIPJALLQVEEQF-UHFFFAOYSA-N 4-(oxiran-2-ylmethoxy)-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1COC(C=C1)=CC=C1N(CC1OC1)CC1CO1 AHIPJALLQVEEQF-UHFFFAOYSA-N 0.000 claims 2
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 claims 2
- USJDOLXCPFASNV-UHFFFAOYSA-N 9-bromononan-1-ol Chemical compound OCCCCCCCCCBr USJDOLXCPFASNV-UHFFFAOYSA-N 0.000 claims 2
- LCFVJGUPQDGYKZ-UHFFFAOYSA-N Bisphenol A diglycidyl ether Chemical compound C=1C=C(OCC2OC2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 LCFVJGUPQDGYKZ-UHFFFAOYSA-N 0.000 claims 2
- 102000013830 Calcium-Sensing Receptors Human genes 0.000 claims 2
- 108010050543 Calcium-Sensing Receptors Proteins 0.000 claims 2
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 claims 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- AIHIHVZYAAMDPM-QMMMGPOBSA-N [(2s)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=CC(S(=O)(=O)OC[C@H]2OC2)=C1 AIHIHVZYAAMDPM-QMMMGPOBSA-N 0.000 claims 2
- MFIBZDZRPYQXOM-UHFFFAOYSA-N [dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silyl]oxy-dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound C1OC1COCCC[Si](C)(C)O[Si](C)(C)CCCOCC1CO1 MFIBZDZRPYQXOM-UHFFFAOYSA-N 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 150000001299 aldehydes Chemical class 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 235000010290 biphenyl Nutrition 0.000 claims 2
- 239000004305 biphenyl Substances 0.000 claims 2
- TXFLGZOGNOOEFZ-UHFFFAOYSA-N bis(2-chloroethyl)amine Chemical compound ClCCNCCCl TXFLGZOGNOOEFZ-UHFFFAOYSA-N 0.000 claims 2
- ZDCTZXKXROPIKF-UHFFFAOYSA-N bis(silyloxysilyloxysilyloxy)silane Chemical compound [SiH3]O[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH3] ZDCTZXKXROPIKF-UHFFFAOYSA-N 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 150000001993 dienes Chemical class 0.000 claims 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical class C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 2
- 230000009977 dual effect Effects 0.000 claims 2
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 claims 2
- 150000002118 epoxides Chemical class 0.000 claims 2
- XWPORILQNZQHJZ-UHFFFAOYSA-N ethyl 5-hydroxy-6,8-bis(oxiran-2-ylmethyl)-4-oxochromene-2-carboxylate Chemical compound C=1C(CC2OC2)=C2OC(C(=O)OCC)=CC(=O)C2=C(O)C=1CC1CO1 XWPORILQNZQHJZ-UHFFFAOYSA-N 0.000 claims 2
- 125000003827 glycol group Chemical group 0.000 claims 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical group [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 claims 2
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 claims 2
- NOQXXYIGRPAZJC-UHFFFAOYSA-N oxiran-2-ylmethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1OC1 NOQXXYIGRPAZJC-UHFFFAOYSA-N 0.000 claims 2
- 239000002307 peroxisome proliferator activated receptor agonist Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 claims 1
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 claims 1
- 229940122720 Alkaline phosphatase inhibitor Drugs 0.000 claims 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims 1
- 229940123208 Biguanide Drugs 0.000 claims 1
- 229940122502 Cholesterol absorption inhibitor Drugs 0.000 claims 1
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 claims 1
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 claims 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 claims 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 claims 1
- 108091052347 Glucose transporter family Proteins 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 claims 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 102000019280 Pancreatic lipases Human genes 0.000 claims 1
- 108050006759 Pancreatic lipases Proteins 0.000 claims 1
- 102100040918 Pro-glucagon Human genes 0.000 claims 1
- 229940123934 Reductase inhibitor Drugs 0.000 claims 1
- 229940100389 Sulfonylurea Drugs 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 claims 1
- 150000004283 biguanides Chemical class 0.000 claims 1
- 229920000080 bile acid sequestrant Polymers 0.000 claims 1
- 229940096699 bile acid sequestrants Drugs 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 229940125753 fibrate Drugs 0.000 claims 1
- 229940121380 ileal bile acid transporter inhibitor Drugs 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 229940116369 pancreatic lipase Drugs 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 claims 1
- 229940044601 receptor agonist Drugs 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000000021 stimulant Substances 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 0 C*(C)CC(C)(C)NC(Nc1ccccc1)=N Chemical compound C*(C)CC(C)(C)NC(Nc1ccccc1)=N 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462093751P | 2014-12-18 | 2014-12-18 | |
| US62/093,751 | 2014-12-18 | ||
| PCT/US2015/066006 WO2016100456A2 (en) | 2014-12-18 | 2015-12-16 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020215991A Division JP2021063229A (ja) | 2014-12-18 | 2020-12-25 | ２型糖尿病の処置のための架橋ポリジアリルアミンコポリマー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501358A JP2018501358A (ja) | 2018-01-18 |
| JP2018501358A5 true JP2018501358A5 (enExample) | 2019-01-31 |
| JP6866293B2 JP6866293B2 (ja) | 2021-05-12 |
Family
ID=55221501
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532699A Expired - Fee Related JP6866293B2 (ja) | 2014-12-18 | 2015-12-16 | ２型糖尿病の処置のための架橋ポリジアリルアミンコポリマー |
| JP2020215991A Pending JP2021063229A (ja) | 2014-12-18 | 2020-12-25 | ２型糖尿病の処置のための架橋ポリジアリルアミンコポリマー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020215991A Pending JP2021063229A (ja) | 2014-12-18 | 2020-12-25 | ２型糖尿病の処置のための架橋ポリジアリルアミンコポリマー |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US11267924B2 (enExample) |
| EP (1) | EP3233090A2 (enExample) |
| JP (2) | JP6866293B2 (enExample) |
| KR (1) | KR20170096008A (enExample) |
| CN (1) | CN107250189A (enExample) |
| AR (1) | AR103175A1 (enExample) |
| AU (1) | AU2015362590A1 (enExample) |
| BR (1) | BR112017012794A2 (enExample) |
| CA (1) | CA2971204A1 (enExample) |
| CL (1) | CL2017001579A1 (enExample) |
| CO (1) | CO2017007119A2 (enExample) |
| CR (1) | CR20170323A (enExample) |
| DO (1) | DOP2017000140A (enExample) |
| EA (1) | EA201791380A1 (enExample) |
| EC (1) | ECSP17045972A (enExample) |
| GT (1) | GT201700133A (enExample) |
| HK (1) | HK1251449A1 (enExample) |
| IL (1) | IL252899A0 (enExample) |
| MA (2) | MA41202A (enExample) |
| MX (1) | MX2017007966A (enExample) |
| PE (1) | PE20171510A1 (enExample) |
| PH (1) | PH12017501120A1 (enExample) |
| SG (1) | SG11201704840RA (enExample) |
| TN (1) | TN2017000253A1 (enExample) |
| TW (1) | TW201636030A (enExample) |
| UY (1) | UY36457A (enExample) |
| WO (1) | WO2016100456A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR109514A1 (es) | 2016-09-09 | 2018-12-19 | Zealand Pharma As | Análogos de amilina |
| US10479865B2 (en) * | 2017-11-01 | 2019-11-19 | Strides Shasun Limited | Process for the preparation of sevelamer carbonate |
| US12295369B2 (en) | 2019-08-07 | 2025-05-13 | Solventum Intellectual Properties Company | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof |
| JP2022548699A (ja) * | 2019-09-20 | 2022-11-21 | グライセンド， インコーポレイテッド | 置換フェニルボロン酸含有ポリマーおよび使用方法 |
| BR112023017628A2 (pt) * | 2021-03-01 | 2023-12-05 | Tricida Inc | Composições farmacêuticas de polímero de poli(alilamina) reticulado |
| IL312600B2 (en) | 2022-05-30 | 2025-12-01 | Zealand Pharma As | Liquid formulations of amylin analogs |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2456428A (en) | 1944-10-11 | 1948-12-14 | Shell Dev | Polyallyl amine and related polymeric amines |
| BE580490A (fr) | 1958-07-15 | 1960-01-08 | Merck & Co Inc | Compositions et procédés pour abaisser la teneur en cholestérol du sang |
| US3104205A (en) | 1959-12-17 | 1963-09-17 | Warner Lambert Pharmaceutical | Deodorant composition comprising the copper complex of the copolymer of allylamine and methacrylic acid |
| US3308020A (en) | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
| US3332841A (en) | 1961-10-04 | 1967-07-25 | Lilly Co Eli | Method of treating hyperacidity |
| BE640616A (enExample) | 1962-12-19 | |||
| US3293195A (en) | 1963-11-29 | 1966-12-20 | Ritter Pfaudler Corp | Ion exchange resins prepared from a mixed resin of vinyl pyridine copolymers and epihalohydrins-polyalkylene polyamines and methods of making and using same |
| US3624209A (en) | 1966-12-28 | 1971-11-30 | Bristol Myers Co | Composition for treatment of gastro-intestinal disorders |
| US3492397A (en) | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
| US4060598A (en) | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| DE1927336A1 (de) | 1968-06-17 | 1969-12-18 | Upjohn Co | Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie |
| US3538214A (en) | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| US3980770A (en) | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
| DK136015B (da) | 1973-02-09 | 1977-08-01 | Sandoz Ag | Fremgangsmåde til fremstilling af en aluminiumhydrogel til anvendelse som phosphatbindingsmiddel. |
| AR206115A1 (es) | 1973-06-11 | 1976-06-30 | Merck & Co Inc | Procedimiento para preparar un polimero lineal no ramificado y no reticulado |
| US4205064A (en) | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
| US4016209A (en) | 1975-04-23 | 1977-04-05 | Merck & Co., Inc. | 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof |
| US4181718A (en) | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
| US4071478A (en) | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
| US4183918A (en) | 1977-03-08 | 1980-01-15 | Exxon Research & Engineering Co. | Detoxifying-medicinal emulsions |
| GB1573487A (en) | 1977-05-23 | 1980-08-28 | Bristol Myers Co | Bile acid binding composition |
| US4143130A (en) | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
| US4368725A (en) | 1977-11-11 | 1983-01-18 | Mcclintock Michael | Solar energy collector |
| US4173626A (en) | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
| US4247393A (en) | 1979-01-11 | 1981-01-27 | Wallace Richard A | Hemodialysis assist device |
| US4439419A (en) | 1980-02-20 | 1984-03-27 | The Upjohn Company | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin |
| US4344993A (en) | 1980-09-02 | 1982-08-17 | The Dow Chemical Company | Perfluorocarbon-polymeric coatings having low critical surface tensions |
| ATE12511T1 (de) | 1980-12-12 | 1985-04-15 | Smith & Nephew Ass | Polymere, deren herstellung und verwendungen. |
| US4504640A (en) | 1982-05-19 | 1985-03-12 | Nitto Boseki Co., Ltd. | Process for producing monoallylamine polymer |
| JPS6090243A (ja) | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | 小球状モノアリルアミン橋かけ重合体の製造方法 |
| DE3572985D1 (en) | 1984-05-11 | 1989-10-19 | Bristol Myers Co | Novel bile sequestrant resin and uses |
| US4631305A (en) | 1985-03-22 | 1986-12-23 | The Upjohn Company | Polymeric material as a disintegrant in a compressed tablet |
| DE3541511A1 (de) | 1985-11-19 | 1987-05-21 | Grace W R Ab | Promoter fuer die papierleimung, verfahren zu dessen herstellung und dessen verwendung |
| AU628389B2 (en) | 1988-08-26 | 1992-09-17 | Pharmacia & Upjohn Company | Fine-beaded colestipol hydrochloride |
| GB8829835D0 (en) | 1988-12-21 | 1989-02-15 | Smith Kline French Lab | Compounds |
| DE3901527A1 (de) | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
| US6274713B1 (en) | 1989-04-07 | 2001-08-14 | Salutar, Inc. | Polychelants |
| US5236701A (en) | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
| US5136032A (en) | 1989-12-07 | 1992-08-04 | Daicel Chemical Industries, Ltd. | Method for separating phosphopolyol compounds using a separating agent |
| US5053423A (en) | 1990-03-22 | 1991-10-01 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
| JPH0687974B2 (ja) | 1990-03-27 | 1994-11-09 | 忠一 平山 | 発熱物質の吸着材料 |
| DE4010271A1 (de) | 1990-03-30 | 1991-10-02 | Basf Ag | Verfahren zur herstellung von ethylenpolymerisaten bei druecken oberhalb von 500 bar in einem rohrreaktor mit einspritzfinger |
| IE914179A1 (en) | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
| RU1808015C (ru) | 1990-12-27 | 1993-04-07 | Владимир Андреевич Шевченко | Способ защиты млекопитающих от воздействи гамма-излучени |
| US5055197A (en) | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
| US5108767A (en) | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
| ATE173931T1 (de) | 1991-07-03 | 1998-12-15 | Upjohn Co | Tabletten mit hohem gehalt an colestipolhydrochlorid |
| EP0534304A1 (de) | 1991-09-21 | 1993-03-31 | Hoechst Aktiengesellschaft | Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika |
| SE470006B (sv) | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
| ATE159262T1 (de) | 1992-07-22 | 1997-11-15 | Hoechst Ag | Hydrophile zentren aufweisende polyvinylamin- derivate, verfahren zu ihrer herstellung sowie die verwendung der verbindungen als arzneimittel, wirkstoffträger und nahrungsmittelhilfsstoff |
| EP0580079B1 (de) | 1992-07-22 | 1996-12-11 | Hoechst Aktiengesellschaft | Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen |
| DK0656029T3 (da) | 1992-08-20 | 1999-02-15 | Du Pont | Tværbundne polymere ammoniumsalte |
| US5302531A (en) | 1992-10-22 | 1994-04-12 | Miles Inc. | Composition for the semiquantitative determination of specific gravity of a test sample |
| DE69330595T2 (de) | 1992-11-25 | 2002-05-23 | Ajinomoto Co., Inc. | Zubereitungen und Nahrungsmittel enthaltend Mineralien und Poly-gamma-Glutaminsäure |
| EP0684958B1 (en) | 1993-02-17 | 1998-06-10 | Btg International Limited | Polymers containing guanidino groups for use in therapy |
| US5487888A (en) | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
| JPH09500368A (ja) | 1993-06-02 | 1997-01-14 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 胆汁酸塩を除去するための組成物および方法 |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| JPH0788181A (ja) * | 1993-09-21 | 1995-04-04 | Mitsubishi Rayon Co Ltd | エンドトキシン吸着材及び製法 |
| US5414068A (en) | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
| WO1996021454A1 (en) | 1995-01-12 | 1996-07-18 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| GB9503061D0 (en) | 1995-02-16 | 1995-04-05 | British Tech Group | Polymeric compounds |
| JP2936129B2 (ja) | 1995-04-12 | 1999-08-23 | セイコー精機株式会社 | 防食構造 |
| FI104823B (fi) | 1996-06-24 | 2000-04-14 | Borealis Polymers Oy | Likaantumista estävä päällyste |
| TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
| JP3389493B2 (ja) | 1997-04-04 | 2003-03-24 | 中外製薬株式会社 | リン酸結合性ポリマー製剤 |
| US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| US5985938A (en) | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
| US6566407B2 (en) | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
| DE19835467A1 (de) | 1998-08-06 | 2000-02-17 | Elenac Gmbh | Feststoffreaktor mit antistatischer Beschichtung zur Durchführung von Reaktionen in der Gasphase |
| TW568788B (en) | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
| US6500527B2 (en) | 2001-02-01 | 2002-12-31 | 3M Innovative Properties Company | Image receptor sheet |
| WO2002085377A1 (en) * | 2001-04-18 | 2002-10-31 | Genzyme Corporation | Method for lowering serum glucose |
| ITMI20021718A1 (it) | 2002-07-31 | 2004-02-01 | Sematic Italia Spa | Interruttore di sicurezza con sistema elettronico programmabile. |
| CA2551528A1 (en) | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
| EP1559419A1 (en) * | 2004-01-23 | 2005-08-03 | Fournier Laboratories Ireland Limited | Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention |
| US20060024368A1 (en) | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
| JPWO2006041150A1 (ja) * | 2004-10-15 | 2008-05-22 | 田辺三菱製薬株式会社 | 糖尿病の予防および／または治療薬 |
| US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| EP2016947A1 (en) * | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
| PA8807201A1 (es) * | 2007-12-14 | 2009-07-23 | Genzyme Corp | Composiciones farmaceuticas |
| ES2549513T3 (es) | 2010-02-24 | 2015-10-28 | Relypsa, Inc. | Polivinilamina, polialilamina y polietilenimina reticuladas para uso como secuestradores de ácidos biliares |
| BR112012021448A2 (pt) | 2010-02-24 | 2016-05-31 | Relypsa Inc | polímero de amina, método para tratar doença, método de remoção de sais biliares de um indivíduo animal, método para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de amina. |
| RU2017106587A (ru) | 2010-02-24 | 2019-01-21 | Релипса, Инк. | Аминосодержащие полимеры для применения в качестве секвестрантов желчных кислот |
| WO2012027331A1 (en) * | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| CA2906501A1 (en) * | 2013-03-15 | 2014-09-25 | Genzyme Corporation | Sequestrants of advanced glycation end product (age) precursors |
-
2015
- 2015-12-15 MA MA041202A patent/MA41202A/fr unknown
- 2015-12-16 KR KR1020177019820A patent/KR20170096008A/ko not_active Withdrawn
- 2015-12-16 MX MX2017007966A patent/MX2017007966A/es unknown
- 2015-12-16 BR BR112017012794A patent/BR112017012794A2/pt not_active Application Discontinuation
- 2015-12-16 EA EA201791380A patent/EA201791380A1/ru unknown
- 2015-12-16 EP EP15828422.4A patent/EP3233090A2/en not_active Withdrawn
- 2015-12-16 JP JP2017532699A patent/JP6866293B2/ja not_active Expired - Fee Related
- 2015-12-16 AU AU2015362590A patent/AU2015362590A1/en not_active Abandoned
- 2015-12-16 TN TN2017000253A patent/TN2017000253A1/en unknown
- 2015-12-16 CA CA2971204A patent/CA2971204A1/en not_active Abandoned
- 2015-12-16 SG SG11201704840RA patent/SG11201704840RA/en unknown
- 2015-12-16 WO PCT/US2015/066006 patent/WO2016100456A2/en not_active Ceased
- 2015-12-16 TW TW104142366A patent/TW201636030A/zh unknown
- 2015-12-16 US US14/971,424 patent/US11267924B2/en not_active Expired - Fee Related
- 2015-12-16 HK HK18104883.2A patent/HK1251449A1/zh unknown
- 2015-12-16 CN CN201580076247.4A patent/CN107250189A/zh active Pending
- 2015-12-16 PE PE2017001082A patent/PE20171510A1/es unknown
- 2015-12-16 MA MA40697A patent/MA40697A1/fr unknown
- 2015-12-16 CR CR20170323A patent/CR20170323A/es unknown
- 2015-12-18 AR ARP150104195A patent/AR103175A1/es unknown
- 2015-12-18 UY UY0001036457A patent/UY36457A/es not_active Application Discontinuation
-
2017
- 2017-06-14 IL IL252899A patent/IL252899A0/en unknown
- 2017-06-14 DO DO2017000140A patent/DOP2017000140A/es unknown
- 2017-06-15 PH PH12017501120A patent/PH12017501120A1/en unknown
- 2017-06-16 GT GT201700133A patent/GT201700133A/es unknown
- 2017-06-16 CL CL2017001579A patent/CL2017001579A1/es unknown
- 2017-07-17 CO CONC2017/0007119A patent/CO2017007119A2/es unknown
- 2017-07-17 EC ECIEPI201745972A patent/ECSP17045972A/es unknown
-
2020
- 2020-12-25 JP JP2020215991A patent/JP2021063229A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210204T1 (hr) | Polimeri koji povezuju protone za oralnu primjenu | |
| US20220002494A1 (en) | Polyorganosilsesquioxane, hard coat film, adhesive sheet, and laminate | |
| JP5486891B2 (ja) | 連鎖硬化性樹脂組成物および繊維強化複合材料 | |
| JP2013504652A5 (enExample) | ||
| ES2624704T3 (es) | Resinas epoxídicas con alta estabilidad térmica y tenacidad | |
| JP5966113B1 (ja) | 有機エレクトロルミネッセンス表示素子用封止剤 | |
| RU2015106941A (ru) | Полимер, содержащий тиоловые группы, и включающая его отверждаемая композиция | |
| JP7160803B2 (ja) | 接着剤用硬化性組成物、接着シート、硬化物、積層物、及び装置 | |
| TW201542669A (zh) | 有機電激發光顯示元件密封用硬化性樹脂組成物、有機電激發光顯示元件密封用硬化性樹脂片、及有機電激發光顯示元件 | |
| RU2015124102A (ru) | Смоляная смесь на основе эпокси(мет)акрилатной смолы и ее применение | |
| JP7060202B2 (ja) | ハードコーティング積層体 | |
| US12297318B2 (en) | Curable resin composition | |
| JP2011006610A5 (enExample) | ||
| JP2013504653A5 (enExample) | ||
| US10759966B1 (en) | Optical laminate and flexible display apparatus comprising the same | |
| KR20190127556A (ko) | 하드 코팅 필름 | |
| KR102125052B1 (ko) | 하드 코팅 조성물 및 이를 이용한 하드 코팅 필름 | |
| CN108137789A (zh) | 用于柔性基底的可固化粘合剂组合物 | |
| US20210230422A1 (en) | Curable composition | |
| JP6957132B2 (ja) | シルセスキオキサン | |
| AR056324A1 (es) | Dispersiones de poliuretano con mejores propiedades de formacion de pelicula | |
| JP7264003B2 (ja) | エポキシ（メタ）アクリレート樹脂組成物、硬化性樹脂組成物、硬化物及び物品 | |
| CN113474393B (zh) | 内窥镜用粘接剂及其固化物、以及内窥镜及其制造方法 | |
| JP7228102B2 (ja) | エポキシ（メタ）アクリレート樹脂組成物、硬化性樹脂組成物、硬化物及び物品 | |
| JP2023037522A (ja) | 重合性不飽和基を有する樹脂組成物、硬化性樹脂組成物、硬化物、及び物品 |